Carmat SA provided earnings guidance for the full year 2023. For the year, CARMAT anticipates a gradual increase in the pace of its production in 2023, which should enable the Company to produce more than 100 artificial hearts and to generate revenue of around 10 million to 13 million as it builds up its inventory of prostheses.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.22 EUR | -6.94% | -15.26% | -51.94% |
Mar. 25 | Carmat: final agreement with creditors | CF |
Mar. 25 | Carmat Secures Two-year Extensions for Bank Loans | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.94% | 91.63M | |
+12.49% | 128B | |
-9.32% | 10.66B | |
-2.20% | 8.55B | |
+15.12% | 7.1B | |
+26.97% | 5.06B | |
+7.09% | 3.4B | |
+0.27% | 3.08B | |
-10.28% | 2.11B | |
-8.61% | 2.03B |
- Stock Market
- Equities
- ALCAR Stock
- News CARMAT
- Carmat SA Provides Earnings Guidance for the Full Year 2023